[1] Article Title: Prevalence and genetic subtypes of congenital myasthenic syndromes in the pediatric population of Slovenia
	•	Line(s): Title section
	•	Section: Title Page / Header
	•	Quote(s): Prevalence and genetic subtypes of congenital myasthenic syndromes in the pediatric population of Slovenia

⸻

[2] Publication Year: 2020
	•	Line(s): Title section
	•	Section: Title Page
	•	Quote(s): European Journal of Paediatric Neurology, Volume 26, May 2020

⸻

[3] Region: Europe
	•	Line(s): Various mentions
	•	Section: Methods, Abstract
	•	Quote(s): …pediatric population of Slovenia.

⸻

[4] Country: Slovenia
	•	Line(s): Multiple
	•	Section: Abstract, Methods
	•	Quote(s): …CMS in pediatric population of Slovenia. / …University Medical Centre, Ljubljana, Slovenia…

⸻

[5] Coverage Area: National
	•	Line(s): Methods
	•	Section: Methods
	•	Quote(s): …retrospective, national, cross-sectional study…

⸻

[6] Study Design: Cross-sectional, retrospective
	•	Line(s): Methods
	•	Section: Abstract, Methods
	•	Quote(s): …In this observational, national, cross-sectional study, medical records were retrospectively reviewed.

⸻

[7] Study Population: Pediatric patients with genetically confirmed CMS
	•	Line(s): Methods
	•	Section: Methods
	•	Quote(s): Children with genetically confirmed CMS, referred over a 19-year period…

⸻

[8] Population Characteristics: Age < 19 years, 3 males and 5 females, all survived study period
	•	Line(s): Results
	•	Section: Prevalence
	•	Quote(s): Eight children (3 males, 5 females)… / …under 19 years of age… / …none of the identified children died…

⸻

[9] Data Source Type: Clinical records and genetic lab data
	•	Line(s): Methods
	•	Section: Abstract, Methods
	•	Quote(s): …medical records were retrospectively reviewed. / Genetic and phenotypic characteristics were collected…

⸻

[10] Data Source Details: University Medical Centre, Ljubljana – sole pediatric neuromuscular referral center in Slovenia
	•	Line(s): Methods
	•	Section: Methods
	•	Quote(s): …referred over a 19 – year period…to the Department of Child, Adolescent and Developmental Neurology, University Medical Centre, Ljubljana…

⸻

[11] Study Timeline Type: Retrospective
	•	Line(s): Methods
	•	Section: Methods
	•	Quote(s): …retrospective, national, cross-sectional study…

⸻

[12] Number of Sites: Single
	•	Line(s): Methods
	•	Section: Methods
	•	Quote(s): …the only specialized pediatric centre for treatment of children with neuromuscular diseases in Slovenia…

⸻

[13] Study Start Year: 2000
	•	Line(s): Methods
	•	Section: Methods
	•	Quote(s): …referred over a 19 – year period (2000–2018)…

⸻

[14] Study End Year: 2018
	•	Line(s): Methods
	•	Section: Methods
	•	Quote(s): …referred over a 19 – year period (2000–2018)…

⸻

[15] Main Ethnicity: NR
	•	Line(s): Not mentioned
	•	Section: NR
	•	Quote(s): NR

⸻

[16] Ethnicity Details: NR
	•	Line(s): Not mentioned
	•	Section: NR
	•	Quote(s): NR

⸻

[17] Disease Studied: Congenital Myasthenic Syndromes (CMS)
	•	Line(s): Title, Abstract, throughout
	•	Section: Title, Abstract, Introduction
	•	Quote(s): …congenital myasthenic syndromes (CMS)…

⸻

[18] Diagnosis Method: Genetic confirmation via molecular testing
	•	Line(s): Abstract, Methods
	•	Section: Abstract, Methods
	•	Quote(s): Children with genetically confirmed CMS… / Genetic molecular testing has improved diagnostics…

⸻

[19] Diagnosis Criteria Details: Confirmation by pathogenic variants in known CMS genes via exome sequencing
	•	Line(s): Introduction
	•	Section: Introduction
	•	Quote(s): Next generation sequencing (NGS) and whole exome sequencing have become important… / …confirmation of the diagnosis and the genetic subtype…

⸻

[20] Disease Phase: Chronic (inferred), though not explicitly stated
	•	Line(s): Introduction
	•	Section: Introduction
	•	Quote(s): …disease usually presents during the first and second year of life with fluctuating weakness…

⸻

[21] Cohort Age Group: Pediatric
	•	Line(s): Multiple
	•	Section: Title, Abstract, Methods
	•	Quote(s): …in the pediatric population… / …children with genetically confirmed CMS…

⸻

[22] Female % in Cohort: 62.5%
	•	Line(s): Results
	•	Section: Prevalence
	•	Quote(s): Eight children (3 males, 5 females)…

⸻

[23] Consanguinity: NR
	•	Line(s): Not reported
	•	Section: NR
	•	Quote(s): NR